Bio-Path Cash Flow - Annual (NASDAQ:BPTH)

Add to My Stocks
$1.08 $0.05 (4.42%) BPTH stock closing price Sep 18, 2018 (Closing)

The financial analysis of BPTH requires an investor to check the cash flows for Bio-Path. Financials statements like the Bio-Path income statement and Bio-Path balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. This statement can tell if a company is running out of money while still being profitable and is useful in Bio-Path stock analysis. Bio-Path had a negative net income cash flow of $-7.02M for the latest 2017. This report is very useful in measuring the short term viability of a company. The cash from operating activities for Bio-Path is $ 2017, which saw an increase from previous year.

View details of Bio-Path cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-7.02M-6.75M-5.46M-4.51M-3.26M-2.58M-2.36M-2.08M-1.96M-2.85M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities-0.2M-0.67M-0.1M---0.02M---0.36M-0.05M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net-1.14M-0.92M-------1.8M
Net Cash from (used by) Operating Activities
-7.95M-8.14M-5M-3.81M-2.31M-1.99M-1.14M-1.14M-1.56M-0.93M
Increase (Decrease) in Prop Plant And Equipment-0.53M-0.33M--0.12M------
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities------0.02M-0.17M-0.22M-0.11M-0.15M
Net Cash from (used by) Investment Activities
-0.53M-0.33M--0.12M--0.02M-0.17M-0.22M-0.11M-0.15M
Issuance (Purchase) of Equity Shares5.08M9M-14.24M5.33M1.6M2.03M1.04M-1.36M
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
5.08M9M-14.24M5.33M1.6M2.03M1.04M-1.36M
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
-3.41M--5M10.3M3.01M-0.41M--0.32M-0.93M-
Cash & Equivalents at Beginning of Year9.37M8.85M13.85M3.55M----1.5M1.21M
Cash & Equivalents at Year End5.96M9.37M8.85M13.85M3.55M----1.5M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Bio-Path stock comparison chart provides an easy way to compare the stock price with peers along with details of Bio-Path stock price history.
The statement of cash flows can be categorized into three main sections:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Bio-Path is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Bio-Path stock price movement.
  • Cash Flow from operating activities: Bio-Path reported a negative operating cash flow of $-7.95M for 2017 and has seen an increase from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.53M for BPTH in last 2017 report.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $5.08M for Bio-Path.

Key Financial Ratios For Bio-Path Cash Flow